As we know, entecavir is a DNA analogue that can inhibit HBV reverse transcription, by integrating itself into HBV genome during viral replication and blocking the cccDNA formation due to lack of hydroxyl group.
But I don't understand how it integrates into the HBV genome, is it through complementary machinery or just integrating into the viral genome randomly?